AACR President Advocates for Federal Investment in Cancer Research
The most recent edition of The Cancer Letter features an op-ed from AACR President David A. Tuveson, MD, PhD,...
The most recent edition of The Cancer Letter features an op-ed from AACR President David A. Tuveson, MD, PhD,...
It’s a familiar tale: Regulatory agencies approve a new cancer treatment, but it comes with an astronomically high price....
Many things come to mind at the mention of New Orleans—jazz, Cajun food, po’ boys, and French-inspired houses with...
On a web page titled “14 Diseases You Almost Forgot About (Thanks to Vaccines),” the Centers for Disease Control (CDC) remind us that the...
Genomic analysis of estrogen receptor (ER)-positive metastatic breast cancer samples that had become resistant to therapies revealed multiple alterations...
Government task force drafts recommendations for low-dose aspirin for the prevention of cardiovascular disease and colorectal cancer; a study...
Patient enrollment in clinical trials has long been on the minds of oncologists and researchers. In 1990, fewer than...
This post originally appeared on the Cancer Today website. “This is a historic time in cancer research,” said Elizabeth...
This post originally appeared on the Cancer Today website. Roads and roadblocks, both literal and metaphorical, figured into a...
Two years ago, amid increased awareness of the need to diversify the scientific work force and end cancer health...
Despite considerable progress against cancer, the disease continues to take a huge toll on global health. Each year, approximately...
Guest post by Patrick Tan, MD, PhD From November 1-3, 2021, Singapore will hold its 13th Frontiers in Cancer...
The dawning of the new year marked the 75th anniversary of the publication of the first issue of Cancer...
Norman E. “Ned” Sharpless, MD, who became director of the National Cancer Institute in October 2017, recently unveiled areas...
Guest post by Andrew T. Chan, MD One of the mechanisms by which the American Association for Cancer Research...
After making great strides for some patients with melanoma and lung cancer, immunotherapy drugs are starting to offer hope...
Excitement and emotion ran high Sunday morning as Margaret Foti, PhD, MD (hc), chief executive officer of the American...
The American Association for Cancer Research (AACR) Annual Meeting 2017 brought some of the world’s greatest scientific minds to...
The term “hackathon” may conjure up images of beanie-wearing coders working in dark basements, trying to build a new...
Earlier this month, the U.S. Food and Drug Administration (FDA) announced that the Office of Hematology and Oncology Products...
Editor’s note: Progress and Promise Against Cancer is the AACR’s initiative to educate the public about cancer and cancer...
The strategic alliance between the American Association for Cancer Research (AACR) and Cancer Research UK (CRUK) includes support for...
In the early 1990s, Gregg Semenza, MD, PhD, was a postdoctoral researcher studying the cellular response to reduced oxygen levels, a...
When the COVID-19 pandemic forced much of the world to shut down, and many days seemed bleak, it was...
“The immuno-oncology revolution is now about 15 years into clinical reality,” said Carl June, MD, FAACR, director of the...
Today’s early-career investigators are the future of cancer research and progress in the quest to prevent and cure cancer....
In recent years, the American Association for Cancer Research (AACR) has expanded its efforts to catalyze advances in cancer...
Guest Post by Sammantha McDonald Past participant in the AACR’s Scientist↔Survivor Program (SSP)
In the early 1970s, German virologist Harald zur Hausen, MD, FAACR, defied the dogma that cervical cancer was caused by the herpes simplex...
One of the most effective ways a person can lower his or her risk of developing cancer is by...